These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 15829371)

  • 21. Prevalence of self-reported screening mammography and impact on breast cancer mortality in Austria.
    Vutuc C; Haidinger G; Waldhoer T
    Wien Klin Wochenschr; 1998 Jul; 110(13-14):485-90. PubMed ID: 9746962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of detection method in predicting breast cancer survival: analysis of randomized screening trials.
    Shen Y; Yang Y; Inoue LY; Munsell MF; Miller AB; Berry DA
    J Natl Cancer Inst; 2005 Aug; 97(16):1195-203. PubMed ID: 16106024
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mammographic screening: patterns of use and estimated impact on breast carcinoma survival.
    Blanchard K; Colbert JA; Puri D; Weissman J; Moy B; Kopans DB; Kaine EM; Moore RH; Halpern EF; Hughes KS; Tanabe KK; Smith BL; Michaelson JS
    Cancer; 2004 Aug; 101(3):495-507. PubMed ID: 15274062
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening mammography was used more, and more frequently, by longer than shorter term Medicaid enrollees.
    Koroukian SM
    J Clin Epidemiol; 2004 Aug; 57(8):824-31. PubMed ID: 15485735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Breast cancer screening by mammography in women aged under 50 years in Japan.
    Morimoto T; Sasa M; Yamaguchi T; Kondo H; Akaiwa H; Sagara Y
    Anticancer Res; 2000; 20(5C):3689-94. PubMed ID: 11268440
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and self breast examination remain important in the era of modern screening.
    Ma I; Dueck A; Gray R; Wasif N; Giurescu M; Lorans R; Pizzitola V; Pockaj B
    Ann Surg Oncol; 2012 May; 19(5):1484-90. PubMed ID: 22160521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The association between the pre-diagnosis mammography screening interval and advanced breast cancer.
    Goel A; Littenberg B; Burack RC
    Breast Cancer Res Treat; 2007 May; 102(3):339-45. PubMed ID: 16927175
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of cancer registry and clinical data as predictors for breast cancer survival.
    Seppänen J; Heinävaara S; Holli K; Hakulinen T
    Cancer Causes Control; 2008 Dec; 19(10):1299-304. PubMed ID: 18752035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patterns and predictors of mammography utilization among breast cancer survivors.
    Doubeni CA; Field TS; Ulcickas Yood M; Rolnick SJ; Quessenberry CP; Fouayzi H; Gurwitz JH; Wei F
    Cancer; 2006 Jun; 106(11):2482-8. PubMed ID: 16634097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mammography screening and the increase in breast cancer incidence in Hawaii.
    Maskarinec G; Wilkens L; Meng L
    Cancer Epidemiol Biomarkers Prev; 1997 Mar; 6(3):201-8. PubMed ID: 9138664
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of breast cancer screening in the community according to risk level.
    Elmore JG; Reisch LM; Barton MB; Barlow WE; Rolnick S; Harris EL; Herrinton LJ; Geiger AM; Beverly RK; Hart G; Yu O; Greene SM; Weiss NS; Fletcher SW
    J Natl Cancer Inst; 2005 Jul; 97(14):1035-43. PubMed ID: 16030301
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening mammography and late-stage breast cancer: a population-based study.
    Wu Y; Weissfeld JL; Weinberg GB; Kuller LH
    Prev Med; 1999 Jun; 28(6):572-8. PubMed ID: 10404555
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Late-stage breast cancer among women with recent negative screening mammography: do clinical encounters offer opportunity for earlier detection?
    Mouchawar J; Taplin S; Ichikawa L; Barlow WE; Geiger AM; Weinmann S; Gilbert J; Manos MM; Ulcickas Yood M
    J Natl Cancer Inst Monogr; 2005; (35):39-46. PubMed ID: 16287884
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Utilization of screening mammography in New Hampshire: a population-based assessment.
    Carney PA; Goodrich ME; Mackenzie T; Weiss JE; Poplack SP; Wells WS; Titus-Ernstoff L
    Cancer; 2005 Oct; 104(8):1726-32. PubMed ID: 16158386
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of mammography for detecting early breast cancer in women under 50.
    Yokoe T; Iino Y; Maemura M; Takei H; Horiguchi J; Matsumoto H; Morishita Y; Koibuchi Y
    Anticancer Res; 1998; 18(6B):4709-11. PubMed ID: 9891545
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Breast cancer yield for screening mammographic examinations with recommendation for short-interval follow-up.
    Kerlikowske K; Smith-Bindman R; Abraham LA; Lehman CD; Yankaskas BC; Ballard-Barbash R; Barlow WE; Voeks JH; Geller BM; Carney PA; Sickles EA
    Radiology; 2005 Mar; 234(3):684-92. PubMed ID: 15734926
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Opinions, beliefs and awareness about the value of mammography screening].
    Steurer J
    Praxis (Bern 1994); 2010 Oct; 99(20):1177-8. PubMed ID: 20954423
    [No Abstract]   [Full Text] [Related]  

  • 38. Positive predictive value of screening mammography by age and family history of breast cancer.
    Kerlikowske K; Grady D; Barclay J; Sickles EA; Eaton A; Ernster V
    JAMA; 1993 Nov; 270(20):2444-50. PubMed ID: 8230621
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early breast cancer deaths in women aged 40-74 years diagnosed during the first 5 years of organised mammography service screening in north Sweden.
    Bordás P; Jonsson H; Nyström L; Cajander S; Lenner P
    Breast; 2004 Aug; 13(4):276-83. PubMed ID: 15325661
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Late stage cancers in a Medicaid-insured population.
    Bradley CJ; Given CW; Roberts C
    Med Care; 2003 Jun; 41(6):722-8. PubMed ID: 12773838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.